An Update on the Management of Esophageal Variceal Hemorrhage
Hassaan A. Zia, Elizabeth S. Aby, Atoosa Rabiee – 26 October 2021
Hepatic Ciliopathy Syndromes
Tamir Diamond, Noor Nema, Jessica Wen – 26 October 2021
Common Gastrointestinal Medications Implicated in Drug‐Induced Liver Injury
Kanika Garg, Jason Kramer, Sheila Eswaran – 26 October 2021
Live Vaccines in Pediatric Liver Transplant Recipients: “To Give or Not to Give”
Sarah Kemme, Taisa J. Kohut, Julia M. Boster, Tamir Diamond, Elizabeth B. Rand, Amy G. Feldman – 26 October 2021
An Update on the Management of Esophageal Variceal Hemorrhage
Hassaan A. Zia, Elizabeth S. Aby, Atoosa Rabiee – 26 October 2021
Language Accessibility of Liver Transplantation Center Websites
Clare E. Jacobson, Alisha Heximer, Robert Olmeda‐Barrientos, Maia S. Anderson, Seth A. Waits, Michael J. Englesbe, Valeria S. M. Valbuena – 26 October 2021
Live Vaccines in Pediatric Liver Transplant Recipients: “To Give or Not to Give”
Sarah Kemme, Taisa J. Kohut, Julia M. Boster, Tamir Diamond, Elizabeth B. Rand, Amy G. Feldman – 26 October 2021
Common Gastrointestinal Medications Implicated in Drug‐Induced Liver Injury
Kanika Garg, Jason Kramer, Sheila Eswaran – 26 October 2021
Hepatic Ciliopathy Syndromes
Tamir Diamond, Noor Nema, Jessica Wen – 26 October 2021
Perceptions of Exercise and Its Challenges in Patients With Nonalcoholic Fatty Liver Disease: A Survey‐Based Study
Oliver Glass, Daniel Liu, Elizabeth Bechard, Cynthia D. Guy, Jane Pendergast, Anna Mae Diehl, Manal F. Abdelmalek – 25 October 2021 – Exercise is a foundational treatment for nonalcoholic fatty liver disease (NAFLD); however, the majority of patients are unable to initiate and maintain effective exercise habits and remain at increased risk for progressive liver disease. Barriers and limitations to exercise in patients with NAFLD have not been fully identified.